BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hou YC, Hu Q, Huang J, Fang JY, Xiong H. Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis. Oncotarget 2017;8:8843-53. [PMID: 27903961 DOI: 10.18632/oncotarget.13633] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Elton AC, Cedarstrom V, Quraishi A, Wuertz B, Murray K, Markowski TW, Seabloom D, Ondrey FG. Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation. Nutr Cancer 2023;:1-14. [PMID: 36688306 DOI: 10.1080/01635581.2023.2165692] [Reference Citation Analysis]
2 Druk IV, Lyalyukova EA, Fadeeva EA. Metformin in the prevention of colorectal cancer with diabetes mellitus. jour 2022. [DOI: 10.31146/1682-8658-ecg-205-9-161-170] [Reference Citation Analysis]
3 Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, Chandrasekaran S, DeFronzo RA, Einhorn D, Galindo RJ, Gardner TW, Garg R, Garvey WT, Hirsch IB, Hurley DL, Izuora K, Kosiborod M, Olson D, Patel SB, Pop-Busui R, Sadhu AR, Samson SL, Stec C, Tamborlane WV Jr, Tuttle KR, Twining C, Vella A, Vellanki P, Weber SL. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr Pract 2022;28:923-1049. [PMID: 35963508 DOI: 10.1016/j.eprac.2022.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
4 Krigel A, Nguyen STT, Talukder N, Huang CH, Buitrago C, Karkenny G, Lebwohl B, Abrams JA, Araujo JL. Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas. Dig Dis Sci 2022;67:4886-94. [PMID: 35022906 DOI: 10.1007/s10620-021-07336-0] [Reference Citation Analysis]
5 Gu L, Ma G, Li C, Lin J, Zhao G. New insights into the prognosis of intraocular malignancy: Interventions for association mechanisms between cancer and diabetes. Front Oncol 2022;12:958170. [DOI: 10.3389/fonc.2022.958170] [Reference Citation Analysis]
6 Rey-Reñones C, Baena-Díez JM, Aguilar-Palacio I, Miquel C, Grau M. Type 2 Diabetes Mellitus and Cancer: Epidemiology, Physiopathology and Prevention. Biomedicines 2021;9:1429. [PMID: 34680546 DOI: 10.3390/biomedicines9101429] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Mitchell A, Price M, Cipriano G. The Prevention and Control of Cancer by Metformin in Patients with Type 2 Diabetes: A Systematic Mapping Review.. [DOI: 10.1101/2021.06.04.21258310] [Reference Citation Analysis]
8 Santiago CN, Rifkin S, Drewes J, Mullin G, Spence E, Hylind LM, Gills JJ, Kafonek D, Cromwell DM, La Luna L, Giardello F, Sears CL; Biofilm Study Consortium. Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps. Cancer Prev Res (Phila) 2021;14:697-708. [PMID: 33947705 DOI: 10.1158/1940-6207.CAPR-20-0664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Piskovatska V, Storey KB, Vaiserman AM, Lushchak O. The Use of Metformin to Increase the Human Healthspan. Adv Exp Med Biol 2020;1260:319-32. [PMID: 32304040 DOI: 10.1007/978-3-030-42667-5_13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
10 Gnesin F, Thuesen ACB, Kähler LKA, Madsbad S, Hemmingsen B. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 2020;6:CD012906. [PMID: 32501595 DOI: 10.1002/14651858.CD012906.pub2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
11 Kato J, Shirakami Y, Shimizu M. Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs. GastrointestDisord 2019;1:273-89. [DOI: 10.3390/gidisord1020023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Piskovatska V, Strilbytska O, Koliada A, Vaiserman A, Lushchak O. Health Benefits of Anti-aging Drugs. Subcell Biochem 2019;91:339-92. [PMID: 30888659 DOI: 10.1007/978-981-13-3681-2_13] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
13 Lu CC, Chiang JH, Tsai FJ, Hsu YM, Juan YN, Yang JS, Chiu HY. Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling. Int J Oncol 2019;54:1271-81. [PMID: 30720062 DOI: 10.3892/ijo.2019.4704] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
14 贺 礼. Research Progress on Anti-Tumor Effect of Metformin in Gastric Cancer. ACM 2019;09:831-836. [DOI: 10.12677/acm.2019.97128] [Reference Citation Analysis]
15 Piskovatska V, Stefanyshyn N, Storey KB, Vaiserman AM, Lushchak O. Metformin as a geroprotector: experimental and clinical evidence. Biogerontology 2019;20:33-48. [PMID: 30255224 DOI: 10.1007/s10522-018-9773-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
16 Schalliol LA, Pittman JM, Ray SD. Insulin and Other Hypoglycemic Drugs. Side Effects of Drugs Annual 2018. [DOI: 10.1016/bs.seda.2018.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]